LEES PHARMACEUTICAL HK LIMITEDcopy_of_logo

LEE'S PHARMACEUTICAL (HK) LIMITED

Lee's Pharm is a public biopharmaceutical company with over 25 years of operation in China's pharmaceutical industry. We are committed to the research and development of innovative products to address unmet medical needs and improve patients’ quality of l

Company

Lee's Pharmaceutical Holdings Limited is a public company with over 25 years of history in the pharmaceutical industry. We focus on several disease areas such as cardiovascular and infectious diseases, ophthalmology, oncology, gynaecology and dermatology. We provide innovative products to combat diseases and improve patients’ quality of life. Lee's has integrated solid infrastructure in drug development, clinical development, registration, manufacturing, sales and marketing. Currently 18 products are available in China, Hong Kong, Macau and Taiwan. Lee's development programme is well recognised, with product pipelines from both internal R&D efforts and partnerships in the US, Europe, Japan, South Korea etc.

Dr. Li Xiaoyi, Lee’s founder and pharmaceutical expert, is dedicated to researching and developing patented drugs. ”Experts in the medical R&D field are passionate about developing new drugs to fight diseases. I am excited to continue on this quest.”

Lee’s Pharm has set up headquarters at Hong Kong Science Park since 2008. HKSTP provides a hub where we can interact and collaborate with innovative partners, and share and discuss our vision and insights.

The information provided on this page is for reference only. Please refer to the latest information published by the partner company.